Commitments and Contingencies (Details) |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
|
Apr. 28, 2020
EUR (€)
|
Mar. 31, 2020
USD ($)
shares
|
Mar. 31, 2019
USD ($)
|
Dec. 31, 2014
shares
|
Mar. 31, 2020
EUR (€)
|
|
| Commitments and Contingencies (Details) [Line Items] | |||||
| Aggregate of security deposit | € | € 110,000 | ||||
| Amount of initial licensing fee | $ | $ 325,000 | ||||
| Percentage of equity interest | 5.00% | ||||
| Shares of equity of common stock | shares | 7,996 | ||||
| Maximum aggregate number of shares issuable | shares | 29,109 | ||||
| Number of share held In escrow of common stock | shares | 21,832 | 7,277 | |||
| Maximum aggregate amount of cash payments due | $ | $ 3,000,000 | $ 2,500,000 | |||
| Tauro Pharm [Member] | |||||
| Commitments and Contingencies (Details) [Line Items] | |||||
| Aggregate of security deposit | $ | $ 170,000 | ||||
| Subsequent Event [Member] | |||||
| Commitments and Contingencies (Details) [Line Items] | |||||
| Estimates expense | € | € 40,000 | ||||